|
December 31, 2006 : Express Pharma : Pfizer's under-trial HIV drug available.
December 19, 2006 : Balancing Act : No solution yet to pricing and availability of drugs.
November 01, 2006 : Modern Pharmaceuticals : Kewal Handa : Interview
October 11, 2006 : HT Patna : Amplodipine cuts diabetes risk.
October 08, 2006 : HBL : Kewal : Pfizer Hold-Results.
October 04, 2006 : BS : Kewal : Pfizer India: Right dose
October 02, 2006 : HBL : Kewal Handa : New drug policy in place.
September 24, 2006 : SIES : Express Pharma : Pharma Vision 2006
September 19, 2006 : Uncertainty is hurting pharma sector.
September 19, 2006 : Economic Times : Executive Lounge.
August 27, 2006 : Business India : A regime that no one wants.
August 15, 2006 : 'Safety monitoring is our No. 1 priority'
July 27, 2006 :Outcomes Research : A holistic approach to patient care.
July 24, 2006 : Not again : Editorial : Business Standard.
July 20, 2006 : The Financial Express : Editorial by Kewal Handa.
July 19, 2006 : More drugs may come under price control : DNA.
July 16, 2006 : Business India : Column authored by Kewal Handa.
June 30, 2006 : Pfizer Q2 up two fold at Rs. 35.89 cr.
June 29, 2006 : Pfizer Q2 net soars to Rs. 36 cr: Punj Lloyd FY06 net drops.
June 29, 2006 : Pfizer net up 132 % to Rs. 36 cr.
June 29, 2006 : Pfizer Q2 up two fold at Rs. 35.89 cr.
June 29, 2006 : Pfizer Q2 up two-fold at Rs. 35.89 cr.
June 28, 2006 : Pfizer Q2 up two fold at Rs. 35.89 cr.
June 28, 2006 : Pfizer India : 23 % Sales growth boosted margins.
June 28, 2006 : Will Data Protection in pharma benefit India : Pro-Debate by Kewal Handa.
June 28, 2006 : Pfizer Q2 net soars 132 % on plant sale.
June 28, 2006 : Pfizer net jumps 145.86 %.
June 09, 2006 : The Fallacy of Price Control : Editorial by Kewal Handa.
| 
Press Releases
